144 - January 2, 2026

The filing indicates a significant liquidity event for Frank Klein, an officer at Rocket Lab, who is offloading 100,000 shares acquired through restricted stock unit (RSU) vestings dating back to November 2024. This transaction is being executed through Morgan Stanley Smith Barney LLC and represents a continuation of selling activity; Klein sold 51,254 shares in late November 2025 across three separate transactions totaling $2,097,131.73. The sale is scheduled to take place on or about January 2, 2026, pursuant to a Rule 10b5-1 trading plan adopted on September 19, 2025.

From a financial oversight perspective, while these sales are often automated for tax obligations or personal diversification, the size of this specific block—valued at nearly $7M—warrants monitoring of executive sentiment. Notably, the filer represents that they possess no material adverse information regarding the company's orbital operations or the development of the Neutron launch vehicle, ensuring compliance with Rule 144 transparency requirements.

This transaction represents a routine but sizeable executive divestment that does not appear to signal fundamental shifts in Rocket Lab's launch manifest or Neutron development timeline. Because the sale is governed by a 10b5-1 plan established months in advance, it minimizes concerns regarding opportunistic liquidations tied to undisclosed technical hurdles. However, the $7M volume adds marginal downward pressure on the stock's immediate float. Investors should view this as standard executive compensation management rather than a lack of confidence in the company's vertical integration strategy or its ability to meet the increasing cadence for Electron and forthcoming Neutron missions.